ClinicalTrials.gov
public full text
Public Domain
Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)
This is the first pilot phase II trial assessing the response of SBRT layered on Darolutamide (BAY1841788) on RPFS and deferring palliative second line systemic therapy in M0CRPC with oligoprogression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer#1378488
- SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study#247036
- Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer#1138300
- Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)#913154
- SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer#811369
Record · ID 1452012
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive